Phase 2 body composition data from the Lancet Diabetes and Endocrinology substudy showed retatrutide achieving fat mass reductions of 15.2% at the 4mg dose, 26.1% at 8mg, and 23.2% at 12mg, while the proportion of lean mass loss relative to total weight loss remained comparable to other GLP-1 compounds
GLP-1 Weight Loss Medications GLP-1 medications are todays leading medical treatment for effective, sustainable weight loss
The peptide appears to influence angiogenesis, the formation of new blood vessels, which is crucial for tissue repair processes
Once reconstituted, peptides require refrigeration at 2-8 degrees Celsius, which standard refrigerators readily provide
Xiong B, Wang Y, Chen Y, Xing S, Liao Q, Chen Y, et al